117 related articles for article (PubMed ID: 9503497)
1. [Onchodermatitis (sowda) in patients in Yémen. Clinical and histologic course after treatment with ivermectin].
al Qubati Y; Reynouard F; Kumar F; Gaxotte P; Richard-Lenoble D
Sante; 1997; 7(6):391-5. PubMed ID: 9503497
[TBL] [Abstract][Full Text] [Related]
2. [Human onchocerciasis and "sowda" in the Republic of Yemen].
Richard-Lenoble D; al Qubati Y; Toe L; Pisella PJ; Gaxotte P; al Kohlani A
Bull Acad Natl Med; 2001; 185(8):1447-59; discussion 1459-61. PubMed ID: 11974966
[TBL] [Abstract][Full Text] [Related]
3. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings.
Ogbuagu KF; Eneanya CI
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S139-45. PubMed ID: 9861280
[TBL] [Abstract][Full Text] [Related]
4. Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis.
Ali MM; Mukhtar MM; Baraka OZ; Homeida MM; Kheir MM; Mackenzie CD
Acta Trop; 2002 Oct; 84(1):49-53. PubMed ID: 12387910
[TBL] [Abstract][Full Text] [Related]
5. Community-based treatment of onchocerciasis with ivermectin in southwest Nigeria: dermatological response to a singledose therapy.
Osungbade KO; Asuzu MC; Kale OO
Afr J Med Med Sci; 2001 Dec; 30(4):352-5. PubMed ID: 14510119
[No Abstract] [Full Text] [Related]
6. Ivermectin treatment of hyperreactive onchodermatitis (sowda) in Liberia.
Darge K; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):206-12. PubMed ID: 8826099
[TBL] [Abstract][Full Text] [Related]
7. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
8. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
[TBL] [Abstract][Full Text] [Related]
9. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial.
Brieger WR; Awedoba AK; Eneanya CI; Hagan M; Ogbuagu KF; Okello DO; Ososanya OO; Ovuga EB; Noma M; Kale OO; Burnham GM; Remme JH
Trop Med Int Health; 1998 Dec; 3(12):951-61. PubMed ID: 9892280
[TBL] [Abstract][Full Text] [Related]
10. [Indication of Mectizan in human medicine other than onchocerciasis].
Richard-Lenoble D
Sante; 1998; 8(1):84-7. PubMed ID: 9592892
[No Abstract] [Full Text] [Related]
11. Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.
Kipp W; Bamhuhiiga J; Rubaale T; Büttner DW
Am J Trop Med Hyg; 2003 Dec; 69(6):621-3. PubMed ID: 14740878
[TBL] [Abstract][Full Text] [Related]
12. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Cupp EW; Cupp MS
Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic image (82). A man with different leg colors. Onchocerciasis].
Verburg GP
Ned Tijdschr Geneeskd; 2002 Mar; 146(13):616. PubMed ID: 11957381
[TBL] [Abstract][Full Text] [Related]
14. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA
Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709
[TBL] [Abstract][Full Text] [Related]
15. [Parnerships and the distribution of Mectizan. The example of the onchocerciasis control program].
Mariko S
Sante; 1998; 8(1):64-5. PubMed ID: 9592885
[No Abstract] [Full Text] [Related]
16. Treatment of equine onchocerciasis with ivermectin paste.
Pollitt CC; Holdsworth PA; Kelly WR; Meacham CS; Sheahan B
Aust Vet J; 1986 May; 63(5):152-6. PubMed ID: 3755903
[TBL] [Abstract][Full Text] [Related]
17. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
[TBL] [Abstract][Full Text] [Related]
18. [Onchocerciasis control program in Chad: the Mectizan donation].
Namangué K
Sante; 1998; 8(1):51-2. PubMed ID: 9592880
[No Abstract] [Full Text] [Related]
19. Reversal of amenorrhoea after Mectizan treatment.
Anosike JC; Abanobi OC
Trop Geogr Med; 1995; 47(5):222-4. PubMed ID: 8553449
[TBL] [Abstract][Full Text] [Related]
20. Onchocerciasis in a nonendemic population: clinical and immunologic assessment before treatment and at the time of presumed cure.
Henry NL; Law M; Nutman TB; Klion AD
J Infect Dis; 2001 Feb; 183(3):512-6. PubMed ID: 11133386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
